Acurx Pharmaceuticals Statistics
NASDAQ: ACXPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.24-0.01 (-0.80%)
Market open · Delayed 15 min · as of Oct 9, 9:50 AM ET
Acurx Pharmaceuticals by the numbers
Acurx Pharmaceuticals has a market capitalization of $6.9 million based on 5.56M shares outstanding. With trailing EPS of $-2.67, Acurx Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 11.7% below its 50-day average and 41.5% below its 200-day average.
Average daily trading volume is 125.08K shares, or about $155,104 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ACXP valuation vs. peer median
| Metric | ACXP | Peer median | Difference |
|---|---|---|---|
| Market cap | $6.89M | $7.02M | -2% |
| Avg. volume | 125.08K | 75.51K | +66% |
Peer median across 8 companies: BOLT, ALZN, TRAW, NRSN, LEXX, APRE, CURX, ENVB.
Valuation
- Market cap
- $6.89M
- EPS (TTM)
- $-2.67
- Shares outstanding
- 5.56M
Price and trading
- Previous close
- 1.25
- Open
- 1.24
- Day range
- 1.24 – 1.25
- 52-week range
- 1.23 – 7.98
- Beta
- —
- Volume
- 6.58K
- Average volume
- 125.08K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 14, 2026
Additional statistics
- Market Cap
- 6.89M
- Forward Pe
- -0.71
- Eps
- -2.67
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 7.98
- Week52 Low
- 1.23
- Avg Volume
- 125.08K
- Shares Outstanding
- 5.56M
- Ma50
- 1.40
- Ma200
- 2.12
- Earnings Date
- Aug 14, 2026
- Pct From52w High
- -84.46%
- Pct From52w Low
- 0.81%